⚖️Correction on 2-Methyl AP-237 Placement in Schedule I by DEA
Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I; Correction
Summary
On March 15, 2024, the Drug Enforcement Administration published a final order placing 1-(2-methyl-4-(3-phenylprop-2-en-1- yl)piperazin-1-yl)butan-1-one (commonly known as 2-methyl AP-237), including its optical and geometric isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. The effective date of that final order was 30 days after publication in the Federal Register. Before the effective date, DEA published another final order that made the instructions for 2-methyl AP-237 in the March 15 final order invalid. This document corrects that error, adding 2- methyl AP-237 and its drug code 9664 for regulatory purposes.
Agencies
- Justice Department
- Drug Enforcement Administration
Business Impact
$$$ - High
The content discusses the placement of 2-methyl AP-237 in Schedule I, which affects businesses involved in pharmaceuticals and controlled substances. Compliance with drug regulations is critical for these businesses, as legal repercussions for non-compliance could lead to financial penalties.